 |
|
|
| |
Outcomes beyond 10 years in entecavir or tenofovir treated
Caucasian chronic hepatitis B patients of the real-life PAGE-B cohort
|
| |
| |
EASL 2025 May 7-10 Amsterdam
G Papatheodoridis1, G Dalekos2, R Idilman3, V Sypsa4, M Buti5JL Calleja6, S Manolakopoulos7, EJ Dongelmans8, M Borghi9, M Papatheodoridi1, N Gatselis2, Z MelekogluEllik3, M Lopez-Gomez6, S Siakavellas7, S Paraskevopoulou1, K Galanis2, Koç3, R Esteban5, HLA Janssen8, P Lampertico9,10
|
| |
|
|
|
|
|
